New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement
FBT
US Health Care
Passive
NYSE listed

First Trust NYSE Arca Biotechnology Index Fund ETF

This ETF provides exposure to Equally Weighted US Biotechnology Equities

FBT performance and flow charts

Last update 4/29/2026 at 7:36 PM
Live
Closed
Last price
$200.47
-$2.81 (-1.38%) Today

Performance

0246810%Mar 27Apr 7Apr 14Apr 21

Flows

0
1 day price range
$198.47
$202.65
52 week price range
$152.93
$221.92
1W perf
-2.52%
YTD perf
-0.95%
YTD flows
+$1.07B
AuM
$2.30B
E/R
0.54%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of April 27, 2026
1M3MYTD1Y3Y5Y
Perf.+7.20%-7.12%-0.95%+26.96%+35.51%+23.43%
Flows-+$57M+$1.07B+$1.08B+$617M+$297M
Data as of April 27, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The First Trust NYSE Arca Biotechnology Index Fund ETF is built to track the NYSE Arca Biotechnology Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderFirst Trust
N° of holdings30
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateJune 19, 2006
ESGNo
TrackinsightTrackinsight

More data and info about FBT on Trackinsight

Exposure

Data as of March 31, 2026

Diversification

56.66%

Total weight of top 15 holdings out of 30

Top 15 Holdings

MODERNA INC
5.14%
ALKERMES
4.16%
UTD THERAPEUT
4.15%
GILEAD SCIENCES
4.08%
CORCEPT THERAPEUTICS
3.94%
AXSOME THERA CMN STK
3.91%
AMGEN-T
3.81%
EXELIXIS
3.52%
KRYSTAL BIOTECH INC
3.49%
BIOGEN INC
3.45%
NEUROCRINE BIOSCIENCES
3.44%
REGENERON PHARMACEUTICALS
3.44%
BIOMARIN PHARMACEUTICAL
3.42%
VERTEX PHARMACEUTICALS
3.39%
US04016X1019
3.32%

Sectors

Health Care
90.59%
Other
9.41%

Countries

USA
95.76%
Other
4.24%
Advertisement

Trading data

Last sale
4/29/2026 at 7:36 PM
$200.47
Previous close
$203.28
Consolidated volume
04/28/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+23.35%+21.73%+20.18%+21.87%
Max drawdown
-13.36%-14.27%-19.92%-29.98%
Max drawdown duration
90d95d237d1243d
Time to recover
N/AN/A176d875d

Replication quality

Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about FBT

What type of ETF is FBT?

FBT is a Passive ETF that provides exposure to Equity assets. It is managed by First Trust.

What index does FBT track?

FBT tracks the NYSE Arca Biotechnology Total Return Index - USD, aiming to replicate its performance through full replication.

What does FBT invest in?

This ETF provides exposure to Equally Weighted US Biotechnology Equities. It is part of the segment: US Health Care.

What is the expense ratio of FBT?

The total expense ratio (TER) of FBT is 0.54%, representing the annual fee charged by the fund manager.

When was FBT launched?

FBT was launched on June 19, 2006, marking its entry into the ETF market.

Who is the issuer of FBT?

FBT is issued by First Trust.

What is the AUM of FBT?

As of April 27, 2026, FBT manages $2.30 B, reflecting the total assets held in the fund.

How has FBT performed recently?

As of April 27, 2026, FBT delivered a return of 7.2% over the past month (1M performance), -7.12% over the past three months (3M), and -0.95% year-to-date (YTD).

How many holdings are in FBT

As of March 31, 2026, FBT holds 30 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is FBT?

As of March 31, 2026, FBT holds 30 securities, with 56.66% of its assets concentrated in its top 15 holdings.

What are the top holdings of FBT?

As of March 31, 2026, FBT holds a portfolio of 30 underlyings, with its largest positions including MODERNA INC, ALKERMES and UTD THERAPEUT. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does FBT invest in?

As of March 31, 2026, FBT has its largest geographic exposures in USA.

What sectors or themes does FBT focus on?

As of March 31, 2026, FBT is primarily exposed to Health Care.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

PRIV ETF

What’sTheFund

What's the Fund | State Street SPDR IG Public & Private Credit ETF (Ticker: PRIV)

Matthew Bartolini, Global Head of Research Strategists, at State Street Investment Management, joins Ethan Hertzfeld on the New York Stock Exchange Floor to discuss PRIV, the State Street SPDR IG Public & Private Credit ETF.

NYSE logo
By NYSE · April 28, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 27, 2026

The ETF Industry saw 23 New Launches, 1 Ticker Change and 4 closures last week.

Tidal
By Tidal · April 28, 2026
Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Asset TV

The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.

Asset TV
By Asset TV · April 22, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 20, 2026

The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.

Tidal
By Tidal · April 22, 2026

Browse all educational columns

Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up